Pneumocystis jiroveci pneumonia: Comparative study of cases in HIV-infected patients and immunocompromised non-HIV-infected patients;Características clínicas, diagnósticas y pronósticas de pacientes con neumonía por Pneumocystis jiroveci en individuos infectados por virus de inmunodeficiencia humana e individuos inmunocomprometidos por otra etiología

Revista Chilena de Infectologia

Volumn 31, Issue 4, 2014, Pages 417-424

  Cerón, Inés ^a   Rabagliati, Ricardo ^a   Langhaus, Javiera ^b   Silva, Felipe ^b   Guzmán, Ana M ^a   Lagos, Marcela ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

HIV; Immunosuppression; Pneumocystis jiroveci; Pneumocystosis; Pneumonia

Indexed keywords

ADULT; AGED; COMPARATIVE STUDY; COMPLICATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; MALE; MIDDLE AGED; MORTALITY; PNEUMOCYSTIS JIROVECI; PNEUMONIA, PNEUMOCYSTIS; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; AGED; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84923343421     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: 10.4067/S0716-10182014000400007     Document Type: Article

References (37)

1. Thomas C F Jr, Limper A H. Pneumocystis pneumonia. N Engl J Med 2004; 350 (24): 2487-98.
2. Sepkowitz K A. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 2002; 34(8): 1098-107.
3. Radisic M, Lattes R, Chapman J F, del Carmen Rial M, Guardia O, Seu F, et al. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study. Transpl Infect Dis 2003; 5 (2): 84-93.
4. Gerrard J G. Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults. Med J Aust 1995; 162 (5): 233-5.
5. Yoo J H, Lee D G, Choi S M, Choi J H, Park Y H, Kim Y J, et al. Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea. Bone Marrow Transplant 2004; 34 (6): 497-504.
6. De Castro N, Neuville S, Sarfati C, Ribaud P, Derouin F, Gluckman E, et al. Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study. Bone Marrow Transplant. 2005; 36 (10): 879-83.
7. Torres H A, Chemaly R F, Storey R, Aguilera E A, Nogueras G M, Safdar A, et al. Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients. Eur J Clin Microbiol Infect Dis 2006; 25(6): 382-8.
8. Sepkowitz K A, Brown A E, Telzak E E, Gottlieb S, Armstrong D. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 1992; 267 (6): 832-7.
9. Hughes W T, Feldman S, Aur R J, Verzosa M S, Hustu H O, Simone J V. Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer. 1975; 36 (6): 2004-9.
10. Kulke M H, Vance E A. Pneumocystis carinii pneumonia in patients receiving chemotherapy for breast cancer. Clin Infect Dis 1997; 25 (2): 215-8.
11. Johnson H D, Johnson W W. Pneumocystic carinii pneumonia in children with cancer. Diagnosis and treatment. JAMA 1970; 214 (6): 1067-73.
12. Walzer P D, Perl D P, Krogstad D J, Rawson P G, Schultz M G. Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med 1974; 80 (1): 83-93.
13. Mansharamani N G, Garland R, Delaney D, Koziel H. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000; 118 (3): 704-11.
14. Roblot F, Godet C, Le Moal G, Garo B, Faouzi Souala M, Dary M, et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 2002; 21(7): 523-31.
15. Arend S M, Kroon F P, van’t Wout J W. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases. Arch Intern Med 1995; 155 (22): 2436-41.
16. Ewig S, Bauer T, Schneider C, Pickenhain A, Pizzulli L, Loos U, et al. Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients. Eur Respir J 1995; 8 (9): 1548-53.
17. Nuesch R, Bellini C, Zimmerli W. Pneumocystis carinii pneumonia in human immunodefciency virus (HIV)-positive and HIV-negative immunocompromised patients. Clin Infect Dis 1999; 29 (6): 1519-23.
18. Kovacs J A, Hiemenz J W, Macher A M, Stover D, Murray H W, Shelhamer J, et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodefciency syndrome and patients with other immunodefciencies. Ann Intern Med 1984; 100 (5): 663-71.
19. Edman J C, Edman U, Cao M, Lundgren B, Kovacs J A, Santi D V. Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene. Proc Natl Acad Sci USA; 86 (22): 8625-9.
20. Li M C, Lee N Y, Lee C C, Lee H C, Chang C M, Ko WC. Pneumocystis jiroveci pneumonia in immunocompromised patients: Delayed diagnosis and poor outcomes in non-HIV-infected individuals. J Microbiol Immunol Infect 2012 Oct 10.
21. Pérez C, Almendarez C, Oddo D, Sirhan M, Labarca J, Acuna G, et al. Pneumonia caused by Pneumocystis carinii in immunodepressed patients: clinical picture, treatment, and prognosis. Rev Med Chile 1994; 122 (2): 154-8.
22. Pérez C, Müller C, Castillo Y, Mella S, Acuña G, Labarca J. Neumonía por Pneumocystis carinii: factores predisponentes, manifestaciones clínicas y respuesta al tratamiento. Rev Chilena Infectol 1999; 16: 296-301.
23. Fischer S, Gill VJ, Kovacs J, Miele P, Keary J, Silcott V, et al. The use of oral washes to diagnose Pneumocystis carinii pneumonia: a blinded prospective study using a polymerase chain reaction-based detection system. J Infect Dis 2001; 184 (11): 1485-8.
24. Larsen H H, Huang L, Kovacs J A, Crothers K, Silcott V A, Morris A, et al. A prospective, blinded study of quantitative touch-down polymerase chain reaction using oral-wash samples for diagnosis of Pneumocystis pneumonia in HIV-infected patients. J Infect Dis 2004; 189 (9): 1679-83.
25. Limper A H, Offord K P, Smith T F, Martin W J, 2nd. Pneumocystis carinii pneumonia. Differences in lung parasite number and infammation in patients with and without AIDS. Am Rev Respir Dis 1989; 140 (5): 1204-9.
26. Kaira K, Shinomiya Y, Takahashi Y, Iida T, Yanagitani N, Sunaga N, et al. Coinfection of invasive pulmonary aspergillosis and Pneumocystis jiroveci pneumonia in a non-HIV patient. Acta Med Okayama 2007; 61 (4): 235-8.
27. Matsumura Y, Shindo Y, Iinuma Y, Yamamoto M, Shirano M, Matsushima A, et al. Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes. BMC Infect Dis 2011; 11: 76.
28. Azoulay E, Bergeron A, Chevret S, Bele N, Schlemmer B, Menotti J. Polymerase chain reaction for diagnosing Pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infltrates. Chest 2009; 135 (3): 655-61.
29. Shelhamer J H, Gill V J, Quinn T C, Crawford S W, Kovacs J A, Masur H, et al. The laboratory evaluation of opportunistic pulmonary infections. Ann Intern Med 1996; 124 (6): 585-99.
30. Sing A, Trebesius K, Roggenkamp A, Russmann H, Tybus K, Pfaff F, et al. Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups. J Clin Microbiol 2000; 38 (4): 1461-7.
31. Medrano F J, Montes-Cano M, Conde M, de la Horra C, Respaldiza N, Gasch A, et al. Pneumocystis jirovecii in general population. Emerg Infect Dis. 2005 Feb; 11(2): 245-50.
32. Ponce C A, Gallo M, Bustamante R, Vargas S L. Pneumocystis colonization is highly prevalent in the autopsied lungs of the general population. Clin Infect Dis 2010; 50 (3): 347-53.
33. Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical signifcance of Pneumocystis colonization. J Infect Dis 2008; 197 (1): 10-7.
34. Kaplan J E, Benson C, Holmes K H, Brooks J T, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58 (RR-4): 1-207; quiz CE1-4.
35. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. Cytotherapy 2001; 3 (1): 41-54.
36. Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 2007; 82 (9): 1052-9.
37. Yale S H, Limper A H. Pneumocystis carinii pneumonia in patients without acquired immunodefciency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 1996; 71 (1): 5-13.